X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,020 | -93,867 | -64,763 | -43,177 | -21,965 |
| Depreciation Amortization | 127 | 513 | 389 | 265 | 133 |
| Accounts payable and accrued liabilities | -1,714 | 3,425 | -481 | -605 | -713 |
| Other Working Capital | 616 | 5,736 | 261 | 391 | -300 |
| Other Operating Activity | -1,521 | 7,091 | 6,585 | 4,423 | 2,616 |
| Operating Cash Flow | $-26,512 | $-77,102 | $-58,009 | $-38,703 | $-20,229 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -103 | -69 | -60 | -22 |
| Investing Cash Flow | $-9 | $-103 | $-69 | $-60 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -381 | N/A | N/A | -439 | -114 |
| Debt Repayment | -1,300 | -795 | -795 | -795 | -795 |
| Common Stock Issued | -443 | 122,839 | 60,693 | 5,855 | 5,877 |
| Other Financing Activity | 0 | -4,814 | -3,312 | -12 | -12 |
| Financing Cash Flow | $-2,124 | $117,230 | $56,586 | $4,609 | $4,956 |
| Exchange Rate Effect | 50 | -105 | -468 | -271 | -69 |
| Beginning Cash Position | 123,028 | 83,108 | 83,108 | 83,108 | 83,108 |
| End Cash Position | 94,433 | 123,028 | 81,148 | 48,683 | 67,744 |
| Net Cash Flow | $-28,595 | $39,920 | $-1,960 | $-34,425 | $-15,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,512 | -77,102 | -58,009 | -38,703 | -20,229 |
| Capital Expenditure | -9 | -103 | -69 | -60 | -22 |
| Free Cash Flow | -26,521 | -77,205 | -58,078 | -38,763 | -20,251 |